The Alliance for Connected Care joined over 45 organizations in a statement to the Drug Enforcement Administration (DEA), requesting explicit guidance to the pharmacy community that the geography of a prescriber in relation to the patient or the pharmacy should not be a “red flag” when a prescription is a result of a telehealth visit.

Read the letter here or below:

Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download [27.70 KB]